Toward a Precision Cure for Chronic Hepatitis B: Convergence of RNA Silencing, Gene Editing, Immune-Reset Therapies, and Artificial Intelligence-Guided Diagnostics
Chronic hepatitis B virus (HBV) infection remains a major global health challenge, affecting over 250 million individuals and causing more than one million deaths annually from cirrhosis and hepatocellular carcinoma. Although current antiviral therapies effectively suppress viral replication, they rarely achieve a func...